Our previous research found that obacunone attenuated experimental colitis in mice through modulation of the gut microbiota, attenuation of TLR4/NF-κB signalling cascades, and restoration of intestinal epithelial barrier integrity (Luo et al. The gene discussed is NFKB1; the disease is colitis.